On December 8th, 2023, the U.S. Food and Drug Administration approved two gene therapy treatments for Sickle cell disease (SCD).1 This is the first time gene therapies have been approved as a potential treatment, marking a breakthrough in medical advancements. This also marks huge strides in the treatment of SCD. Previously, symptoms could be treated, […]